title: The effect of different solutions for organ preservation on immediate postischemic pancreatic function in vitro.
abstract: The present study compares the effect of organ preservation with Euro-Collins solution, cardioplegic histidine-tryptophan-ketoglutarate solution, and University of Wisconsin solution on immediate pancreatic function after cold storage at 4 degrees C for 24 hr. Postischemic organ quality of a porcine pancreas preparation was tested by quantification of physiological and biomedical parameters in a one-line reperfusion system. During reperfusion with a constant arterial pressure the arteriovenous flow rate was significantly higher for HTK (5.7 +/- 0.91 ml/min, n = 8; P < 0.05 vs. EC) and UW (7.4 +/- 0.81 ml/min, n = 8; P < 0.05 vs. EC) than for EC (3.0 +/- 0.26 ml/min, n = 6). The lowest lactate content in the reperfusate was found after HTK protection (HTK, 64.0 +/- 7.2 mumol/50 ml, n = 8; versus EC, 114.2 +/- 1.7 mumol/50 ml, n = 6, P < 0.001; versus UW, 148.0 +/- 28.6 mumol/50 ml, n = 8, P < 0.05). Amylase in the venous effluent was significantly lower (P < 0.05) for HTK or UW protection than for EC (HTK, 189 +/- 72.6 U/ml; UW, 188 +/- 39.4 U/ml; EC, 416 +/- 71.7 U/ml). Oxygen consumption during reperfusion was significantly higher for HTK (2.15 +/- 0.22 microliters/g/min, P < 0.001) and UW (1.80 +/- 0.52 microliters/g/min, P < 0.05) than for EC (0.47 +/- 0.13 microliters/g/min). We conclude that immediate postischemic organ quality and pancreatic function after protection with HTK is not inferior to preservation with UW.
authors.affiliation: Department of Medicine, University of Göttingen, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Leonhardt
authors.forename: A
authors.initials: A
authors.lastname: Tytko
authors.forename: B
authors.initials: B
authors.lastname: Exner
authors.forename: M
authors.initials: M
authors.lastname: Barthel
authors.forename: F
authors.initials: F
authors.lastname: Stöckmann
authors.forename: H
authors.initials: H
authors.lastname: Köhler
authors.forename: E G
authors.initials: EG
authors.lastname: Siegel
authors.forename: K
authors.initials: K
authors.lastname: Nebendahl
authors.forename: W
authors.initials: W
authors.lastname: Creutzfeldt
mesh_terms: D000241:Adenosine; D000493:Allopurinol; D000818:Animals; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione; D006982:Hypertonic Solutions / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin; D008353:Mannitol / Q000494:pharmacology; D009926:Organ Preservation; D019188:Organ Preservation Solutions; D010179:Pancreas / Q000187:drug effects* / Q000473:pathology / Q000502:physiology*; D011189:Potassium Chloride / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D011887:Raffinose; D015424:Reperfusion; D012996:Solutions / Q000494:pharmacology*; D013552:Swine
chemical_list: C039984:Bretschneider cardioplegic solution; C037096:Euro-Collins' solution; D006982:Hypertonic Solutions; D007328:Insulin; D019188:Organ Preservation Solutions; D012996:Solutions; C055206:University of Wisconsin-lactobionate solution; D008353:Mannitol; D011343:Procaine; D000493:Allopurinol; D011189:Potassium Chloride; D005978:Glutathione; D005947:Glucose; D000241:Adenosine; D011887:Raffinose